Wednesday, June 10, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Blockchain

Diginex’s All-Stock $1.5 Billion AI Deal Puts a Nasdaq Lifeline in Reach

Kennethcix by Kennethcix
April 25, 2026
in Blockchain, Tech & Software, Turnaround
0
Diginex Stock
0
SHARES
22
VIEWS
Share on FacebookShare on Twitter

Diginex is attempting a high-wire act: buying a high-growth AI platform for $1.5 billion in equity while scrambling to keep its Nasdaq listing alive. The company announced on April 24, 2026, that it has signed a definitive agreement to acquire Resulticks, an AI-driven data platform, in an all-stock transaction valued at $1.32 per share.

The deal marks a dramatic pivot for Diginex, which is repositioning itself from a pure ESG software vendor into a builder of global compliance infrastructure. Chairman Miles Pelham framed the acquisition as a bet on real-time data — moving sustainability metrics out of static reports and into live business workflows. Resulticks, which embeds data into operational systems rather than producing backward-looking documentation, provides the technological engine for that shift.

Resulticks generated roughly $150 million in revenue in fiscal 2025, with an EBITDA margin of 32%. The company has posted annual revenue growth of around 70% over the past five years. For 2026, management forecasts sales of between $190 million and $210 million.

The transaction is expected to close within 30 to 45 days. Because it is structured entirely in Diginex shares, there is no cash outflow, but existing shareholders face significant dilution.

A Nasdaq Clock Ticking Until September

The timing of the deal is tight. On March 23, 2026, Diginex received a non-compliance notice from Nasdaq after its stock closed below the $1.00 minimum bid price for 30 consecutive trading days. The company now has until September 21, 2026, to lift the share price above that threshold for a sustained period — or risk delisting.

The acquisition’s $1.32-per-share valuation sits above the Nasdaq minimum, raising the possibility that the deal’s structure alone could mathematically push the stock over the line. Whether that holds in practice depends on how the market prices the massive share count expansion that comes with the all-stock consideration.

Should investors sell immediately? Or is it worth buying Diginex?

Shareholders have already cleared the way for potential capital adjustments. At an extraordinary general meeting in April, more than 99% of votes cast approved measures that allow the board to pursue structural changes, including a reverse stock split.

A New Leadership Team Takes the Helm

To execute the transformation, Diginex is reshaping its management. Jacob Friedman has been appointed Chief Operating Officer, and Sandra Kovacheva steps in as Chief Administrative Officer. They join CEO Lubomila Jordanova, who has led the company since the start of the year.

The new team faces the immediate challenge of integrating the recently acquired capabilities. The focus is on expanding AI-powered solutions for enterprise clients, combining blockchain technology with artificial intelligence to reduce errors in climate data collection and supply chain audits. The goal is to embed sustainability data directly into customers’ existing data infrastructure, making it usable for operational decisions rather than just regulatory reporting.

Four Units, One Platform

Internally, Diginex is consolidating its four operating divisions — Diginex, Plan A, Matter and The Remedy Project — into a single unified platform. The board has approved the blueprint for the current fiscal year, with a detailed integration strategy expected in the second quarter of 2026. That timeline places the rollout squarely in the middle of the Nasdaq compliance window.

The company’s financial ambitions remain bold. Management is targeting revenue of up to $280 million by 2027. But the path to that goal runs through a narrow corridor: the Resulticks deal must close smoothly, the internal restructuring must deliver, and the stock must hold above $1.00 — all before September. If any piece falters, the Nasdaq delisting risk becomes very real.

Ad

Diginex Stock: Buy or Sell?! New Diginex Analysis from June 9 delivers the answer:

The latest Diginex figures speak for themselves: Urgent action needed for Diginex investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 9.

Diginex: Buy or sell? Read more here...

Tags: Diginex
Kennethcix

Kennethcix

Related Posts

T-Mobile US Stock
Market Commentary

T-Mobile US Balances Price Hikes with Subscriber Growth as Defensive Appeal Draws Investor Interest

June 9, 2026
Dell Stock
Earnings

Dell’s AI Boom Masks a Brutal Margin Reality as Shares Slide

June 9, 2026
Alphabet Stock
AI & Quantum Computing

Alphabet’s $460 Billion Cloud Backlog Fuels a Record AI Spending Spree

June 9, 2026
Next Post
Almonty Stock

Almonty's Options Frenzy Signals a Catalyst Is Brewing

Nvidia Stock

Nvidia Hits $5 Trillion Market Cap as Blackwell Backlog Hits 3.6 Million Units

DroneShield Stock

DroneShield’s Subscription Ambitions Take Centre Stage After Record Quarter

Recommended

Telecommunications Industry Stock Exchange

Unusual Options Activity Indicates Mixed Sentiment for Verizon Communications

2 years ago
FuelCell EnergyPref Stock

Scaling Up: FuelCell Energy’s Path to Commercialization

3 months ago
Super League Gaming Inc Stock

A Pivotal Week for Super League Gaming’s Strategic Trajectory

8 months ago
Eli Lilly and Stock

Eli Lilly Secures Dual Regulatory Wins with New Cancer and Alzheimer’s Therapies

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Dell’s AI Boom Masks a Brutal Margin Reality as Shares Slide

Bitzero Surges on $2.6B Norwegian Cloud Deal and Nasdaq Listing

Alphabet’s $460 Billion Cloud Backlog Fuels a Record AI Spending Spree

NOVONIX Revamps Executive Team as Shares Hit Fresh Lows

Meta’s $115 Million Workforce Playbook: Academy, Breach, and a Thai Lawsuit All in One Week

Rocket Lab’s Classified Hypersonic Test and $200M Quarter Highlight a Pivotal Week for Space Stocks

Trending

Bayer Stock
Analysis

Bayer’s Slow Build: Clinical Evidence and Margin Pressures Define the Next Chapter

by Rodolfo Hanigan
June 9, 2026
0

Bayer is attempting to write a new chapter, one built on clinical proof rather than corporate promises....

T-Mobile US Stock

T-Mobile US Balances Price Hikes with Subscriber Growth as Defensive Appeal Draws Investor Interest

June 9, 2026
Verbio Stock

Verbio Shares Tumble 18% in a Week as Oil Price Swings Hit the Sector

June 9, 2026
Dell Stock

Dell’s AI Boom Masks a Brutal Margin Reality as Shares Slide

June 9, 2026
Bitzero Stock

Bitzero Surges on $2.6B Norwegian Cloud Deal and Nasdaq Listing

June 9, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Bayer’s Slow Build: Clinical Evidence and Margin Pressures Define the Next Chapter
  • T-Mobile US Balances Price Hikes with Subscriber Growth as Defensive Appeal Draws Investor Interest
  • Verbio Shares Tumble 18% in a Week as Oil Price Swings Hit the Sector

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com